Comparative effectiveness of immune checkpoint inhibitors in squamous vs. non-squamous cervical carcinoma: a systematic review and meta-analysis of randomized controlled trials

Li-Fang Lan, Yu-Jie Chen, Dun-Chang Mo, Wen-Yi Li, Fei Yu · 2026

Read Comparative effectiveness of immune checkpoint inhibitors in squamous vs. non-squamous cervical carcinoma: a systematic review and meta-analysis of randomized controlled trials by Li-Fang Lan, Yu-Jie Chen, Dun-Chang Mo, Wen-Yi Li, Fei Yu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13357105.txt.

Description

Li-Fang Lan and four co-authors present a review and pooled analysis from 2026 on drug treatment for cervical cancer that has spread. They ask whether immune checkpoint drugs help patients with the squamous form of the disease more or less than patients with other forms.

The team searched three large databases and found four trials that fit. Pooling the results, the drugs improved survival and slowed the disease in both groups. Some drug types helped one group more than the other, though. The authors say care should be matched to the type of cancer a patient has, not given the same way to all.

Catalog record

CREATORLi-Fang Lan, Yu-Jie Chen, Dun-Chang Mo, Wen-Yi Li, Fei Yu
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE25 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13357105

Browse the full library · About the Tower of Babel